Clinical Trial Update: Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating pharmacokinetics of lisdexamfetamine in post-bariatric surgery patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery-related Pharmacokinetic Changes
• Lisdexamfetamine-associated Disorders

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: North Dakota State University | Conditions: Lisdexamfetamine | Phase 4 | Status: UNKNOWN